How Propanc Biopharma Is Joining the Fight with Cancer Patients Who Are Increasingly Vulnerable to the COVID-19 Global Pandemic Apr 16, 2020
Propanc Biopharma Receives First Allowance for Key Patent Family from Australian Patent Office Apr 14, 2020
Propanc Biopharma’s Scientific Advisory Board Member Promoted to Professorship Position at Jaén University, Spain Mar 16, 2020
Propanc Biopharma Receives Advance Overseas Finding from Innovation and Science Australia Jan 21, 2020
Propanc Biopharma Illustrates Novel Mode of Action of PRP, Suppressing EMT Pathways and Metastasis in Cancer Patients Oct 21, 2019
